CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)

NCT07254962 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Head Neck Cancer
Mouth Cancer
Throat Cancer
Larynx Cancer
Skin Cancer Face

Interventions

DRUG: Capecitabine
OTHER: Standard of Care (SOC)

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital

Collaborators

[object Object]
[object Object]